Vaccines
aim to elicit a robust, yet targeted, immune response.
Failure of a vaccine to elicit such a response arises in part from
inappropriate temporal control over antigen and adjuvant presentation
to the immune system. In this work, we sought to exploit the immune
system’s natural response to extended pathogen exposure during
infection by designing an easily administered slow-delivery vaccine
platform. We utilized an injectable and self-healing polymer–nanoparticle
(PNP) hydrogel platform to prolong the codelivery of vaccine components
to the immune system. We demonstrated that these hydrogels exhibit
unique delivery characteristics, whereby physicochemically distinct
compounds (such as antigen and adjuvant) could be codelivered over
the course of weeks. When administered in mice, hydrogel-based sustained
vaccine exposure enhanced the magnitude, duration, and quality of
the humoral immune response compared to standard PBS bolus administration
of the same model vaccine. We report that the creation of a local
inflammatory niche within the hydrogel, coupled with sustained exposure
of vaccine cargo, enhanced the magnitude and duration of germinal
center responses in the lymph nodes. This strengthened germinal center
response promoted greater antibody affinity maturation, resulting
in a more than 1000-fold increase in antigen-specific antibody affinity
in comparison to bolus immunization. In summary, this work introduces
a simple and effective vaccine delivery platform that increases the
potency and durability of subunit vaccines.